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Abstract
Numerous microbial pathogens modulate or interfere with cell death pathways in cultured cells. However, the precise role
of host cell death during in vivo infection remains poorly understood. Macrophages infected by pathogenic species of
Yersinia typically undergo an apoptotic cell death. This is due to the activity of a Type III secreted effector protein,
designated YopJ in Y. pseudotuberculosis and Y. pestis, and YopP in the closely related Y. enterocolitica. It has recently been
reported that Y. enterocolitica YopP shows intrinsically greater capacity for being secreted than Y. pestis YopJ, and that this
correlates with enhanced cytotoxicity observed for high virulence serotypes of Y. enterocolitica. The enzymatic activity and
secretory capacity of YopP from different Y. enterocolitica serotypes have been shown to be variable. However, the
underlying basis for differential secretion of YopJ/YopP, and whether reduced secretion of YopJ by Y. pestis plays a role in
pathogenesis during in vivo infection, is not currently known. It has also been reported that similar to macrophages, Y.
enterocolitica infection of dendritic cells leads to YopP-dependent cell death. We demonstrate here that in contrast to Y.
enterocolitica, Y. pseudotuberculosis infection of bone marrow–derived dendritic cells does not lead to increased cell death.
However, death of Y. pseudotuberculosis–infected dendritic cells is enhanced by ectopic expression of YopP in place of YopJ.
We further show that polymorphisms at the N-terminus of the YopP/YopJ proteins are responsible for their differential
secretion, translocation, and consequent cytotoxicity. Mutation of two amino acids in YopJ markedly enhanced both
translocation and cytotoxicity. Surprisingly, expression of YopP or a hypersecreted mutant of YopJ in Y. pseudotuberculosis
resulted in its attenuation in oral mouse infection. Complete absence of YopJ also resulted in attenuation of virulence, in
accordance with previous observations. These findings suggest that control of cytotoxicity is an important virulence
property for Y. pseudotuberculosis, and that intermediate levels of YopJ-mediated cytotoxicity are necessary for maximal
systemic virulence of this bacterial pathogen.
Citation: Brodsky IE, Medzhitov R (2008) Reduced Secretion of YopJ by Yersinia Limits In Vivo Cell Death but Enhances Bacterial Virulence. PLoS Pathog 4(5):
e1000067. doi:10.1371/journal.ppat.1000067
Editor: Ralph R. Isberg, Tufts University School of Medicine, United States of America
Received February 15, 2008; Accepted April 11, 2008; Published May 16, 2008
Copyright:  2008 Brodsky, Medzhitov. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by the New England RCE, AI057159. IB is supported by a postdoctoral NRSA grant 1 F32 AI065081. RM is an investigator of the
Howard Hughes Medical Institute.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: igor.brodsky@yale.edu (IEB); ruslan.medzhitov@yale.edu (RM)
Introduction
It is generally thought that the ability of bacterial pathogens to
cause host cell death in vitro is important for virulence in vivo [1].
However the role of host cell killing in bacterial virulence during in
vivo infections remains poorly understood. Whether a particular
optimal level of cell death might exist during bacterial infection,
and how such a level might be achieved is a question that has not
yet been addressed. Standard genetic approaches to investigate the
basis of microbial pathogenesis typically screen or select for loss of
function mutants in which a particular virulence property is
completely abrogated. However, modulating the level of activity of
individual virulence factors by bacterial pathogens has been shown
to be important for maximizing overall virulence. This may be
because of two opposing selective pressures that act on any given
virulence property: positive selection for enhanced bacterial
replication is countered by a selection for reduced host detection.
Thus, because host organisms possess mechanisms to sense
infection and are likely to respond to disruption of signaling
pathways, bacterial pathogens must evolve additional mechanisms
for modulating an initial baseline activity of particular virulence
factor. For example, during the process of cell invasion, the activity
of the Salmonella GEF protein SopE is counteracted by the
phosphatase SptP [2], and this activity of SptP is important for
limiting TNF-a production by Salmonella infected cells [3].
Additionally, replacement of the Listeria monocytogenes pore-forming
toxin LLO with the related but much more active toxin PFO leads
to attenuated bacterial replication in vitro and in vivo [4]. We
wished to examine whether bacterial proteins that trigger cell
death might also possess an optimal level of activity for a given
bacterial pathogen. We therefore devised a system in which the
cytotoxicity of the facultative extracellular pathogen Yersinia
pseudotuberculosis could be altered in a tunable fashion. This
approach enabled us to uncover a requirement for limiting the
extent of cell death during the course of animal infection that has
not previously been appreciated in studies of Yersinia virulence.
The Gram negative genus Yersinia contains three pathogenic
species whose close evolutionary relationship provides an ideal
system with which to investigate the evolution of bacterial
virulence [5]. Y. pestis (the etiologic agent of plague) and Y.
pseudotuberculosis are the most closely related, with Y. pestis believed
to have recently evolved from Y. pseudotuberculosis [5]. Y. enterocolitica
comprises a more distantly related, heterogeneous group of
biotypes that are both highly pathogenic and non-pathogenic in
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a tropism for lymphoid tissues. Interestingly, despite the shared
enteric lifestyle of Y. pseudotuberculosis and Y. enterocolitica, highly
virulent serotypes of the latter appear to trigger more acute
pathology in infected tissues[6], and have a 10-50-fold lower LD50
in experimental mouse infections [7,8]. This difference in
pathology and virulence characteristics may reflect diverse
selection pressures faced by these two species over the course of
their evolution away from a common ancestor.
All three pathogenic Yersinia species harbor a virulence plasmid
of approximately 70 kB that encodes a Type III Secretion System
(TTSS) as well as secreted effector proteins designated Yersinia
outer proteins or Yops [9,10]. The virulence plasmid interferes
with key immune functions during infection [11,12,13,14].
However, the tropism of Yersinia species for lymphoid tissue
appears to be dependent upon bacterial chromosomal factors, as
bacteria lacking the virulence plasmid can still colonize mesenteric
lymph nodes following oral infection [15].
Among the best studied aspects of Yersinia infection is its
cytotoxicity toward mammalian macrophages. This cytotoxicity is
caused by a type III secreted effector protein, designated YopJ in
Y. pestis and pseudotuberculosis and YopP in Y. enterocolitica [16,17].
YopJ and YopP interfere with NF-KB and MAPK signaling
pathways in infected cells, leading to a block in cytokine secretion
and macrophage death [13,18]. Studies have suggested that the
mechanism of YopJ activity lies in its ability to deubiquitinate
signaling proteins, including TRAF6 and IKKb, that are required
for NF-kB and MAPK responses to bacterial infection [19,20].
More recent studies propose that YopJ/P acylates substrates such
as MKK6 and MEK2 which prevents their subsequent phosphor-
ylation and activation [21,22]. Regardless of the precise
mechanism, it is clear that one of the major consequences of
Yersinia infection is the YopJ/P-dependent death of infected
macrophages, and that YopJ contributes to systemic virulence
following mouse oral infection [23].
Despite the close evolutionary relationship between the
pathogenic Yersiniae, heterogeneity exists among Yersinia enterocolitica
isolates with respect to the presence or absence of a high-affinity
iron-transport system encoded by the high pathogenicity island
(HPI) [24,25], and presence or absence of YopT among Y.
pseudotuberculosis isolates [26]. It has also been observed that YopP
of different Y. enterocolitica serotypes can differ in enzymatic activity
due to the presence of an arginine/serine polymorphism at amino
acid 143 [27]. The presence of R143 correlates with high virulence
among Y. enterocolitica isolates [28]. Although YopJ of Y. pestis and
Y. pseudotuberculosis contains the R143 polymorphism associated
with higher activity, it was recently shown that YopP from the
high-virulence Y. enterocolitica O:8 serotype is more cytotoxic to
macrophages than YopJ of Y. pestis, and expression of YopP in Y.
pestis increases its in vitro cytotoxicity [29]. This difference in
cytotoxicity was shown to be due to an increase in the secretion of
YopP relative to YopJ of Y. pestis. However, the basis for reduced
secretion of YopJ, and whether control of Yop secretion plays a
role in Yersinia virulence in vivo remains unknown.
Studies on the interaction of Y. enterocolitica and DCs have
suggested that like macrophages, DCs are highly susceptible to
killing by Yersinia infection, and that this killing is dependent upon
the activity of YopP [30]. Other studies have indicated that killing
of DCs by Y. enterocolitica interferes with the priming of adaptive T
cell responses in infected mice [31]. More recent work has further
suggested that blocking of MAPK pathways by YopP in DCs
infected by Y. enterocolitica prevents DC pinocytosis and antigen
uptake [32].
Our initial examination of Y. pseudotuberculosis infection of DCs
did not show high levels of cell death, although in accordance with
previous studies, macrophages showed significant levels of cell
death in response to the same infectious dose of Y. pseudotuberculosis.
Our studies therefore reveal that DCs are markedly more resistant
than macrophages to induction of cell death by Y. pseudotuberculosis,
in contrast to previous reports indicating that both DC and
macrophage cytotoxity is limited during Y. pestis infections [29,33].
We suspected that Y. pseudotuberculosis may thus have evolved a
species-specific means of reducing its cytotoxicity toward DCs. We
demonstrate that two amino acid polymorphisms in the N-
terminus of YopJ and YopP are responsible for controlling their
levels of secretion and translocation, which correlates directly with
the extent of cytotoxicity of Y. pseudotuberculosis relative to Y.
enterocolitica and their differential ability to inhibit MAPK
activation in infected dendritic cells. The biological importance
of this reduced DC cytotoxicity was revealed upon infection of
mice with Y. pseudotuberculosis strains that differed in their
cytotoxicity toward DCs: surprisingly, we found that enhancing
cytotoxicity of Y. pseudotuberculosis resulted in its attenuation
following oral infection. This level of attenuation was similar to
that seen with a yopJ deficient strain of Y. pseudotuberculosis [23].
These data suggest that maximal virulence of Y. pseudotuberculosis
requires an intermediate level of YopJ-mediated cytotoxicity.
Results
Dendritic cells are more resistant than macrophages to
apoptosis induced by YopJ but not YopP
We initiated our studies by examining the extent of cell death in
macrophages and dendritic cells infected with Y. pseudotuberculosis
and Y. enterocolitica. Macrophage death following infection with
Yersinia occurs through caspase-3 by a pathway involving Bid
cleavage [34]. We therefore examined cleavage of the Caspase-3
substrate poly-ADP ribose polymerase (PARP) as a means of
comparing the extent of cell death in macrophages and dendritic
cells (DCs). PARP was cleaved in macrophages infected either with
Y. enterocolitica or Y. pseudotuberculosis at low and high MOI, as
Author Summary
The ability of bacterial pathogens to modulate death of
infected host cells is an important virulence determinant.
For pathogenic members of the genus Yersinia, the type III
secreted effector protein YopJ/YopP is required for
Yersinia-induced macrophage death. The YopJ protein is
expressed by Y. pseudotuberculosis, while the ninety-four
percent identical YopP protein is expressed by Y.
enterocolitica. Y. enterocolitica infection also triggers
YopP-dependent killing of dendritic cells, which are critical
antigen presenting cells of the immune system. We
demonstrate that in contrast to macrophages, dendritic
cells are resistant to Y. pseudotuberculosis-mediated
cytotoxicity. However, Y. pseudotuberculosis expressing
YopP in place of YopJ was highly cytotoxic toward
dendritic cells. This difference in cytotoxicity was attribut-
able to a difference in the delivery of YopJ and YopP into
mammalian cells. Furthermore, mutation of two amino
acids at the N-terminus of YopJ enhanced its delivery and
cytotoxicity. Remarkably, we found that enhancing the
cytotoxicity of Y. pseudotuberculosis by expression of YopP
led to its attenuation in a mouse model of Yersinia
infection. This indicates that optimal virulence for a given
pathogen requires careful regulation of virulence proper-
ties and highlights the potential evolutionary tradeoffs
between cellular cytotoxicity and in vivo virulence.
Yersinia Virulence Enhanced by Low YopJ Secretion
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culosis showed no cleavage of PARP at low MOI, and only very
low levels of PARP cleavage at high MOI. This was in contrast to
DCs infected with Y. enterocolitica, which had high levels of PARP
cleavage at both low and high MOI (Figure 1B). Death of Yersinia-
infected macrophages is mediated by the YopJ/YopP proteins
[16,17]. We therefore used the low copy plasmid pACYC184 to
complement a yopJ mutant of the Y. pseudotuberculosis strain IP2666
with either yopJ (called pYopJ) from Y. pseudotuberculosis or yopP
(called pYopP) from Y. enterocolitica. Complementation with pYopJ
or pYopP resulted in PARP cleavage in Y. pseudotuberculosis infected
macrophages; however, only expression of YopP in Y. pseudotuber-
culosis enabled PARP cleavage in infected DCs (Figure 1A and 1B).
We confirmed that caspase-3 was indeed differentially activated in
DCs infected by these various strains of Yersinia using a cell-
permeable fluorescent caspase-3 substrate. Consistent with the
extent of PARP cleavage, a much greater percentage of cells
activated caspase-3 following infection with either Y. enterocolitica or
Y. pseudotuberculosis expressing YopP than cells infected with Y.
pseudotuberculosis expressing YopJ (Figure 1C). Macrophages were
not more permissive for Yop translocation than DCs, as equivalent
levels of a YopE-b lactamase reporter fusion protein were
translocated into both macrophages and DCs (Table S2). It is
also unlikely that differential attachment of Y. pseudotuberculosis to
DCs accounts for the observed difference, as expression of YopP
alone in Y. pseudotuberculosis was sufficient to cause markedly
increased caspase-3 activation and PARP cleavage in DCs.
MAPK activation in dendritic cells is more potently
inhibited by YopP than YopJ
The observation of increased PARP cleavage and caspase-3
activation in DCs infected with Y. pseudotuberculosis expressing YopP
but not YopJ suggested an intrinsic difference between YopJ and
YopP. Recent studies showed that although Y. pestis and Y.
enterocolitica infection show equivalent inhibition of macrophage
p38 MAPK activation, Y. pestis YopJ and Y. enterocolitica YopP are
differentially translocated into infected macrophages [29]. Mac-
rophages infected by Yersinia are thought to undergo cell death due
to inhibition of NF-kB and MAPKs by YopJ/P in the context of
stimulation by bacterial LPS [35,36]. This is due to the
requirement for NF-kB and MAPK signaling in the synthesis of
anti-apoptotic gene products following treatment with pro-
inflammatory stimuli [37].We therefore examined MAPK activa-
tion in dendritic cells following Yersinia infection.
Figure 1. Y. enterocolitica YopP induces apoptosis more potently than Y. pseudotuberculosis YopJ in dendritic cells. (A) PARP cleavage
was measured by immunoblotting of macrophage and (B) dendritic cell lysates after infection with indicated Y. pseudotuberculosis (Yp) and Y.
enterocolitica (Ye) strains at indicated multiplicity of infection (MOI). P- indicates bacteria lacking the virulence plasmid. Immunoblots are
representative of 3 independently infected preparations of cells. (C) NucView
TM 488 Caspase-3 fluorescent substrate labeling of dendritic cells
infected at an MOI of 5 with indicated bacterial strains.
doi:10.1371/journal.ppat.1000067.g001
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bacteria of either species rapidly phosphorylated p38 and SAPK/
JNK; in contrast, wild-type Y. enterocolitica completely blocked p38
and SAPK/JNK phosphorylation but Y. pseudotuberculosis did not
(Figure 2A and B). This suggested that in contrast to prior
observations in macrophages, dendritic cells are differentially
sensitive to MAPK inhibition by YopJ or YopP. Indeed, the
increased inhibition of MAPK activation in DCs infected with Y.
Figure 2. YopP inhibits MAPK activation to a greater extent than YopJ. (A) Cell lysates from dendritic cells infected for indicated number of
minutes with wild type Y. pseudotuberculosis or enterocolitica (Yp or Ye, respectively) or their virulence plasmid-deficient counterparts (YpP- or YeP-)
were probed for phospho-p38 and total p38. (B) Identical cell lysates as in (A) were probed for phospho-SAPK/JNK and total SAPK/JNK. (C) Cell lysates
from dendritic cells infected with Yp DyopJ expressing either YopP or YopJ as indicated were probed for phospho- and total-MAPK proteins as in (A)
and (B). All immunoblots are representative of three independently performed experiments. (D) Flow cytometry analysis of annexinV-positive DCs
treated with vehicle (DMSO) or the p38 inhibitor SB202190 immediately prior to being left untreated, treated with LPS, or infected with Yp, YpP-, Ye,
or YeP-. Data are represented as bar graphs of the mean of triplicate samples, and are representative of three independently performed experiments.
doi:10.1371/journal.ppat.1000067.g002
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alone in Y. pseudotuberculosis was sufficient to inhibit p38 and
SAPK/JNK phosphorylation to virtually the same extent as Y.
enterocolitica (Figure 2C). Notably, kinetics of MAPK activation in
cells infected with virulence plasmid- deficient bacteria differed
markedly between Y. enterocolitica and Y. pseudotuberculosis: activation
of both p38 and SAPK/JNK was much more rapid in YeP-
infected cells than YpP- infected cells. This may be due to subtle
differences in the LPS of Y. enterocolitica and Y. pseudotuberculosis,a s
heat killed bacteria showed similar differences in kinetics of
MAPK activation (data not shown). We did not observe
differential inhibition of NF-kB activation in DCs infected with
Y. enterocolitica and Y. pseudotuberculosis (data not shown). This
suggested that increased MAPK inhibition was primarily respon-
sible for the increased death of DCs infected by Y. enterocolitica.
Indeed, specific inhibition of p38 in the context of wild-type Y.
pseudotuberculosis infection was sufficient to increase dendritic cell
death to nearly the same extent as cells infected by Y. enterocolitica
(Figure 2D). That this effect was not due to nonspecific increase in
death was demonstrated by LPS-treated DCs or DCs infected with
Y. pseudotuberculosis lacking the virulence plasmid, which did not
show dramatically increased death upon p38 MAPK inhibition.
Together with the PARP cleavage, these data indicated that an
intrinsic difference between the YopJ and YopP proteins was most
likely responsible for the differences in phenotypes observed
between Y. enterocolitica and Y. pseudotuberculosis.
Enhanced dendritic cell death in Y. enterocolitica-infected
cells is due to N-terminal polymorphisms that enhance
secretion and translocation of YopP relative to YopJ
Recent work has indicated that Y. pestis YopJ and Y. enterocolitica
YopP are differentially translocated into infected macrophages
when expressed from a strong promoter on a high-copy plasmid
[29]. However, the basis for this differential translocation is
unknown. We therefore examined the in vitro secretion of Yops
from a yopJ mutant of Y. pseudotuberculosis expressing YopJ or YopP
on a low copy plasmid, as well as from wild-type Y. pseudotuberculosis
and Y. enterocolitica. Similarly to published observations [38,39],
YopJ of Y. pseudotuberculosis was poorly detected in bacterial culture
supernatants, in contrast to YopP which was easily observed by
SDS-PAGE of TCA-precipitated Yersinia culture supernatants
(Figure 3A). YopP ectopically expressed in Y. pseudotuberculosis also
was secreted at higher levels than YopJ (Figure 3A). The yopP
coding sequence alone was sufficient for this enhanced secretion,
since replacement of the yopJ protein coding sequence with that of
yopP, generating a plasmid designated pYopJP, resulted in
markedly greater levels of protein secretion than the pYopJ or
the converse pYopPJ plasmid (Figure 3A). A schematic diagram of
the construction of pYopJP and pYopPJ is provided in supporting
information (Figure S1A).
Type III secretion in Yersinia is thought to depend upon both
mRNA and primary amino acid sequences within the first 10–15
codons/amino acids of the secreted effector protein [40,41,42,43].
We examined this region of YopP and YopJ for insight into the
basis of their differential secretion. The coding sequences of yopP
and yopJ have four nucleotide polymorphisms within this region
(Figure S1B). Two of these polymorphisms are synonomous
changes, while two are non-synonomous, resulting in an IS to SP
change at amino acids 10 and 11. We therefore generated
mutations in the yopJ coding sequence of plasmids pYopJ and
pYopPJ, creating substitutions in all 4 polymorphic nucleotides.
These plasmids were designated pYopJn or pYopPJn, and
demonstrate that whereas wild-type YopJ is poorly secreted,
mutation of 4 nucleotides at the 59 end of yopJ is sufficient to
markedly enhance secretion of YopJ (Figure 3A, compare YopPJ
to YopPJn). We separated the non-synonomous and synonomous
mutations by making constructs pYopPJ2aa, with ISRSP amino
acid changes in YopJ, and pYopPJ2nt, with two nucleotide
changes in yopJ but no alteration of the YopJ protein sequence
(Figure S1C). Mutation of ISRSP was in fact sufficient to enhance
YopJ secretion, indicating that the YopJ/P amino acid sequence
was primarily responsible for the level of secretion (Figure S1D). In
order to measure the amount of protein actually translocated into
infected cells, we constructed reporter plasmids encoding a GSK
tag in the pYopJ, pYopP, pYopJn and pYopPJn plasmids. This tag
is phosphorylated by host cell Ser/Thr kinases only upon
translocation of the fusion protein into the cytosol, and is therefore
a useful tool to measure the extent of protein translocation [44].
Indeed, we observed that the translocation of YopP and YopPJn
was significantly higher than that of YopJ and YopJn, as detected
by levels of phospho-GSK fusion protein (Figure 3D, left panel).
Furthermore, levels of translocated YopJn were notably higher
than levels of translocated YopJ. The amount of total GSK fusion
protein was similar for all of the constructs (Figure 3D, right
panel), indicating that differences in steady-state level of total
protein were not responsible for differences in translocation.
We next examined the extent of cell death caused by infection
with Y. pseudotuberculosis strains harboring these plasmids. As
expected and consistent with the known role of of YopJ/P in
macrophage death, an increase in macrophage cell death occurred
upon infection with any of the strains containing pYopJ, pYopP or
chimeric and mutant, but not vector control, plasmids, demon-
strating their functionality (Figure 3C). In contrast, death of DCs
occurred only when they were infected by strains containing
plasmids mediating high levels of YopJ/P protein secretion,
specifically pYopP, pYopJP, and pYopPJn (Figure 3D). These
plasmids also mediate high levels of Yop/P protein translocation,
suggesting that increased levels of translocated YopJ/P are directly
responsible for increased death of DCs. Interestingly, although
YopJn-GSK was also translocated at higher levels than YopJ-
GSK, this was not enough to markedly enhance the level of cell
death in DCs infected with YopJn-expressing bacteria (Figure 3D).
This suggests that a fairly high threshold of YopJ activity is
necessary to induce death of DCs, and that this threshold is
significantly higher than for macrophages. Together, these results
indicate that Y. enterocolitica has much greater levels of cytotoxicty
toward DCs than Y. pseudotuberculosis, that this cytotoxicity is
dependent upon the degree of YopP secretion and translocation,
and that the cytotoxicity of Y. pseudotuberculosis toward DCs can be
significantly increased by inducing high levels of YopJ transloca-
tion.
Evolutionary selection for differential secretion of YopP
and YopJ
Y. enterocolitica comprises a heterogeneous group of strains that
differ with respect to their degree of virulence in animal infections.
The primary basis for this difference is the presence or absence of
a ‘High pathogenicity island’ (HPI) encoding an iron transport
system [25]. Interestingly, the presence of the HPI shows strong
correlation with the presence of arginine at amino acid 143 of
YopP [27]. These two traits also correlate with apparently
increased secretion of YopP, as the Y. enterocolitica serotypes which
lack the HPI also appear to secrete less YopP [28]. Based on our
analysis of the N-terminal polymorphisms between YopP from Y.
enterocolitica 8081 and Y. pseudotuberculosis YopJ, we examined YopP
sequences from strains of Y. enterocolitica O:8 (high virulence) and
O:9 (low virulence) serotypes, as well as YopJ sequences from Y.
pestis. We found that all sequenced strains of Y. pestis and Y.
Yersinia Virulence Enhanced by Low YopJ Secretion
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positions 10 and 11, which correlates with reduced secretion
(Figure 4). In contrast, O:8 serotype, high virulence, strains of Y.
enterocolitica possess the serine-proline sequence which confers high
secretion. Interestingly, the O:9 serotype low virulence Y.
enterocolitica strains also possessed a mutation at position 11,
encoding a phenylalanine rather than serine found in YopP from
high virulence strains (Figure 4). YopP from the low virulence O:9
strains has been suggested to be secreted at lower levels than YopP
expressed by O:8 serotype strains [28]. This raised the possibility
that secretion of YopJ/YopP itself is a selectable trait that may
play a differential role in virulence depending on the particular
Yersinia species and serotype in which it is expressed. In order to
examine this possibility in greater detail, we investigated the
consequences of animal infection caused by Y. pseudotuberculosis
expressing YopP or YopJ.
YopP mediates greater cell death than YopJ in tissues
during in vivo infection
Both Y. enterocolitica and Y. pseudotuberculosis cause cell death
within infected tissues in vivo. Yet, a direct side-by-side
comparison between the two species during in vivo infection is
difficult due to unique gene products present or absent in one or
the other species. We therefore directly examined the in vivo
consequences of modulating Y. pseudotuberculosis cytotoxicity: we
infected mice orally with either YopJ- or YopP-expressing Y.
Figure 3. Extent of YopJ/YopP secretion correlates with degree of dendritic cell death following Yersinia infection. (A) TCA-
precipitated supernatants from indicated bacterial strains analyzed by SDS-PAGE and Coomassie blue staining. (B) Cell lysates from HeLa cells
infected with yopJ mutant Y. pseudotuberculosis expressing indicated GSK fusion proteins analyzed by Western blotting for levels of translocation of
GSK fusion protein (anti-phospho-Ser9-GSK) and for levels of total GSK fusion protein (anti-GSK3b aa1-13). White arrow indicates phospho-GSK fusion
protein, black arrow indicates total GSK-tagged fusion protein. Grey arrows indicate endogenous phospho-GSK and GSK. (C) Percentage of bone
marrow derived macrophages that stain positively with annexinV/propidium iodide (PI) 8 hrs post-infection at MOI of 20 with indicated bacterial
strains. Dotted line indicates background staining of uninfected cells. (D) Percentage of bone marrow derived dendritic cells that stain positively with
PI 16–18 hrs post-infection at MOI of 20 with indicated bacterial strains. Graphs are representative of 3 independently infected preparations of cells,
performed in triplicate. p values obtained by Student’s unpaired two-tailed t-test.
doi:10.1371/journal.ppat.1000067.g003
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tissues by terminal dUTP nick-end labeling (TUNEL) staining
four days post-infection. Consistent with our in vitro observa-
tions, mice infected with the YopP-expressing strain of Y.
pseudotuberculosis showed markedly increased levels of TUNEL-
positive cells in mesenteric lymph nodes among both CD11b
+
(primarily macrophage) and CD11c
+ (primarily dendritic cell)
populations (Figure 5A). B220
+ (primarily B cell) populations also
showed increased levels of TUNEL staining in mesenteric lymph
nodes of mice infected with YopP-expressing bacteria relative to
mice infected with YopJ-expressing bacteria (data not shown).
This suggests that in vivo, multiple cell subsets are susceptible to
Yersinia-induced cell death. Further microscopic examination also
suggested than in mice infected with YopP-expressing bacteria,
cell death was more widely distributed within the infected tissues,
whereas in mice infected with YopJ-expressing bacteria, dead or
dying cells were more tightly clustered within a smaller area
(Figure 5B). In order to further corroborate and quantify these
findings, we enumerated TUNEL
+ cells in infected tissue
sections. Significantly more TUNEL
+ cells were present in the
spleen and lymph node sections of mice infected with YopP-
expressing bacteria than in the mice infected with YopJ-
expressing bacteria, although no significant differences were
observed in the Peyer’s patches (Figure 5B). In vivo, higher
numbers of CD11b
+ cells were TUNEL
+ in YopP-infected mice
than YopJ-infected mice despite the observation that bone
marrow derived macrophages were equally susceptible to death
following infection with YopP- or YopJ-expressing bacteria
(Figure 4B). However, we have observed that at low multiplicities
of infection, YopP-expressing bacteria are more cytotoxic than
YopJ-expressing bacteria to bone marrow derived macrophages
as well (Figure S2). This may suggest that the actual multiplicity
of infection within infected tissues is likely to be fairly low, even
at later timepoints post-infection. An alternative possibility is that
macrophages in vivo may behave slightly differently with respect
to Yersinia-induced cell death than bone marrow derived
macrophages in culture.
Increased cytotoxicity attenuates in vivo virulence of Y.
pseudotuberculosis
We investigated the impact of this increased cytotoxicity on the
virulence of Y. pseudotuberculosis by examining bacterial growth in
tissues of mice infected with the yopJ mutant strain reconstituted
with either YopJ or YopP. Surprisingly, we found that the more
cytotoxic (YopP-expressing) Y. pseudotuberculosis strain was attenu-
ated following oral infection: mice infected with bacteria
expressing YopP had significantly lower colony forming units
(cfu) in the spleen at days 3 and 5 post-infection, and in mesenteric
lymph nodes on day 5 post-infection (Figure 6A). Due to the acute
nature of the infection, not enough mice infected with YopJ-
expressing bacteria survived to be able to isolate tissues at day 7.
The Y. pseudotuberculosis strain containing only the vector, and
therefore completely lacking YopJ, was as deficient as the YopP-
expressing strain for replicating in the spleen, consistent with the
requirement of YopJ for this aspect of Yersinia virulence [23]
(Figure 6A). Importantly, 97–100% of bacteria recovered from
mouse tissues maintained the pYopJ or pYopP plasmids for at least
seven days following oral infection, and the YopP-expressing
bacteria maintained their increased in vitro cytotoxicity upon
reisolation from infected organs (data not shown).
Levels of pro-inflammatory cytokines were markedly elevated in
sera obtained from mice infected with YopJ-expressing bacteria
compared with those infected either with YopP-expressing bacteria
or the isogenic yopJ-deficient bacteria containing only vector
(Figure 6B). Elevated levels of TNF-a and IL-6 were observed on
day 3 post-infection, and rose dramatically along with IFN-c and IL-
12 on day 5, coincident with the increase in bacterial load in the
spleen. Surprisingly, lower levels of cytokines were observed in mice
infected with either YopP-expressing bacteria or bacteria lacking
yopJ (vector), despite the ability of the mice to limit the systemic
replication of these strains. Furthermore, survival of mice infected
with YopP-expressing bacteria was markedly greater than that of
mice infected with bacteria expressing YopJ (Figure 6C). This
indicated that excessive cytotoxicity was detrimental to Y. pseudotu-
berculosis replication and virulence in vivo. We obtained similar
Figure 4. N-terminal sequence polymorphisms determine differential secretion of YopP/YopJ proteins. N-terminal 14 amino acids of
YopP and YopJ from various Yersinia strains and serotypes. O:8 serotypes of Y. enterocolitica possess an SP sequence at positions 10 and 11, whereas
Y. pseudotuberculosis and Y. pestis possess the IS sequence. O:9 serotypes of Y. enterocolitica also possess a polymorphism at amino acid 11, which
likely accounts for the reduced secretion of YopP by O:9 serotypes. Ye – Y. enterocolitica, Ype – Y. pestis, Yps – Y. pseudotuberculosis. Ype Med. – Y.
pestis, biovar Medievalis.
doi:10.1371/journal.ppat.1000067.g004
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plasmid (Figure S3). Although this strain hyper-secretes YopJ and is
morecytotoxic invitro than wild-typeY. pseudotuberculosis (Figure 3),it
too is attenuated in vivo as measured by survival of infected mice
(Figure S3). These data indicate that limiting cytototoxicity during
infection through control of YopJ secretion is critical for optimal
virulence of Y. pseudotuberculosis.
Discussion
Successful infection of mammalian organisms by microbial
pathogens is often associated with disruption of cell death
homeostasis within infected tissues. Triggering of host-cell death
is thought to be an important virulence characteristic of many
facultative pathogenic bacteria, since deletion of individual
Figure 5. YopP-expressing Y. pseudotuberculosis causes enhanced killing of cells within lymphoid tissue during mouse infection. (A)
TUNEL staining analyzed by flow cytometry of mesenteric lymph node cells isolated day 4 post-infection from mice given PBS as controls or infected
with yopJ mutant Y. pseudotuberculosis expressing YopJ or YopP. CD11b and CD11c populations represent primarily macrophage and dendritic cell
populations, respectively. Data are representative of six mice per group for infected mice and three mice for PBS controls. Percentage of double
positive cells is indicated in each dot plot. Bar graphs represent mean percentage of double positive cells for six infected mice for each bacterial strain
or three PBS control treated mice. (B) Spleen sections from mice infected with YopJ- or YopP- expressing bacteria as in (A), isolated on Day 4 post-
infection and stained with TUNEL reagent and DAPI. Scale bar=40 mM. (C) Enumeration of TUNEL
+ nuclei from spleen, mesenteric lymph node, and
Peyer’s patch sections isolated four days post-infection with YopJ- (light grey bars) or YopP- (dark grey bars) expressing yopJ mutant Y.
pseudotuberculosis. Data are averages of at least 10 random fields per mouse per tissue averaged from three mice per group. Similar results were
obtained for two independent infections. p values were calculated using the unpaired Student’s t-test.
doi:10.1371/journal.ppat.1000067.g005
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PLoS Pathogens | www.plospathogens.org 8 May 2008 | Volume 4 | Issue 5 | e1000067Figure 6. YopP-expressing Y. pseudotuberculosis is attenuated and induces lower levels of serum cytokine production during mouse
infection. (A) Bacterial CFUs present in tissues of mice infected with Yp DyopJ containing either empty vector (white triangles) or expressing YopJ (grey
squares) or YopP (grey circles) at days 3, 5, and 7 after oral infection. Mice infected with YopJ-expressing Yp DyopJ were moribund or dead from
overwhelming infection at the end of day 6. (B) Serum cytokine levels of infected mice from (A) collected on days 3 (white bars), 5 (light grey bars), and 7
(darkgreybars).(C)SurvivalcurveofmiceinfectedwithYopJ-(greysquares)orYopP-(greycircles)expressingYpDyopJ.pvalues for bacterialcfuandserum
cytokine levels were calculated using unpaired 2-tailed Student’s t-Test. p value for mouse survival curves was calculated using log-rank test.
doi:10.1371/journal.ppat.1000067.g006
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death leads, in many cases, to attenuation of virulence in
experimental infection models [1]. However, it is likely that
evolution of any given microbial pathogen has led to an optimized
set of virulence traits in which any particular characteristic, such as
the ability to cause cell death, is tightly regulated in relation to the
other traits. We examined this hypothesis by using a system in
which the degree of cytotoxicity could be modulated. We chose
Yersinia as a model system, because, despite the close evolutionary
relatedness of the pathogenic Yersiniae, they are heterogeneous in
the extent of cell death and pathology that they cause during
infection [6,27]. This provides optimal conditions for testing
whether the degree of cell death caused by a particular member of
a related group of organisms might be an evolutionarily selected
trait.
Recent studies have shown that two of the pathogenic Yersinia
species, Y. enterocolitica and Y. pestis, possess varying degrees of
cytotoxicity, and that Y. enterocolitica YopP is translocated more
efficiently into cells than the homologous protein YopJ of Y. pestis
[29]. These studies also demonstrated that expressing YopP from a
strong promoter on a high copy plasmid in Y. pestis enhanced the
ability of Y. pestis to cause macrophage cell death in vitro.
Variation also exists among different serotypes of Y. enterocolitica
with respect to both YopP activity [27] and degree of secretion
[28]. However, nothing is currently known about the contribution
of differential YopJ/YopP secretion to cytotoxicity or virulence of
Yersinia during in vivo infection. Furthermore, the underlying basis
for the differential secretion of YopP and YopJ, as well as
differential secretion of YopP among individual Y. enterocolitica
isolates, remains unclear.
The work presented here demonstrates that YopP and YopJ are
differentially secreted and translocated due to a polymorphism in
amino acids 10 and 11 between Y. pseudotuberculosis YopJ and Y.
enterocolitica YopP. Polymorphisms at amino acid 11 are also likely
to account for differences in secretion of YopP among different Y.
enterocolitica serotypes. However, these amino acids are identical
among YopJ proteins from sequenced strains of Y. pseudotuberculosis
and Y. pestis. This suggests that selection pressures driving this
difference in secretion between the Y. enterocolitica and Y.
pseudotuberculosis proteins were maintained in the recent evolution
of Y. pestis from Y. pseudotuberculosis. It is interesting to note that
while Y. pestis YopJ contributes to host cell death and blocks
cytokine secretion in vitro, as it does for enteric Yersiniae, it appears
to be nonessential for virulence in a rat model of bubonic plague
[45]. Our study suggests that expression of YopP or a
hypersecreted form of YopJ in Y. pestis may also attenuate
virulence during in vivo infection. Our data also indicate that
despite inducing higher levels of cell death in infected tissues
(Figure 5), Y. pseudotuberculosis expressing YopP were attenuated for
colonizing and possibly replicating within the spleen and
mesenteric lymph nodes (Figure 6). An intermediate level of YopJ
protein delivery therefore appears necessary for maximal viru-
lence, as bacteria completely lacking YopJ are also deficient in
colonization of the spleen following oral infection, consistent with
earlier studies [23]. Recent work indicates that YopJ is not
required for replication of Y. pseudotuberculosis in the spleen if the
bacteria are delivered intraperitoneally, bypassing the intestinal
route [46]. Our results therefore indicate a requirement for
intermediate levels of YopJ delivery in mediating spread of
bacteria to the spleen from initial sites of colonization within the
intestine.
The underlying basis for why increasing cytotoxicity of Y.
pseudotuberculosis infection leads to attenuation are not clear at this
time, but could involve an intracellular stage during in vivo
infection [47,48]. Excessive cytotoxicity may lead to death of cells
that provide an important intracellular niche for Y. pseudotubercu-
losis, potentially for purposes of spreading from the initial site of
colonization to other tissues. Recent evidence indicates that spread
of Y. pseudotuberculosis to the spleen following oral infection occurs
directly from a replicating pool within the intestinal lumen,
through a pathway that bypasses the mesenteric lymph nodes [49].
Interestingly, despite the differential susceptibility of bone-marrow
derived macrophages and dendritic cells to YopJ-mediated killing
(Figures 1 and 3), it appears that at least within mesenteric lymph
nodes, both CD11b
+ (primarily macrophage) and CD11c
+
(primarily dendritic) cell populations showed either high or
intermediate levels of cell death when infected by YopP- or YopJ-
expressing Y. pseudotuberculosis (Figure 5). A particular phagocytic
cell subset within the Peyer’s patches or intestinal lamina propria
may be responsible for transporting Yersinia from the intestine to
systemic sites, and these cells may be differentially susceptible to
YopJ-mediated cell death. Recent work has highlighted the role of
a particular subset of dendritic cells within the lamina propria,
designated CX3CR1
+ cells, in uptake of Salmonella typhimurium
[50,51]. Investigation of the particular cell types that interact with
Yersinia during intestinal colonization and the utilization of mouse
models enabling dendritic cell depletion are likely to provide
further insight into the mechanism of Yersinia spread to internal
tissues.
That higher in vitro cytotoxicity of Y. pseudotuberculosis can lead
to markedly reduced virulence is somewhat surprising, particularly
since we observed reduced cytokine production as well as
increased cell death in mice infected with the more cytotoxic,
YopP-expressing bacteria. An alternative hypothesis for the
requirement for intermediate levels of cytotoxicity during Y.
pseudotuberculosis infection is that proinflammatory cytokines
produced during wild-type Y. pseudotuberculosis infection could
contribute to bacterial spread by promoting tissue destruction.
This could be blocked during infection with YopP-expressing Y.
pseudotuberculosis due to death of cytokine-producing cells. In
support of this model, recent work has shown that mice infected
with the attenuated Dpla strain of Y. pestis control the infection
without producing high levels of cytokines in contrast to wild-type
infected mice, which fail to control the infection despite high levels
of cytokine production [52]. These observations may reflect the
possibility that appropriate control of bacterial replication must
occur very early during the infection process. The outcome of a
bacterial infection depends on the interplay between host
clearance mechanisms and bacterial virulence factors; misregula-
tion of bacterial virulence factors as we observed with expression of
YopP in place of YopJ therefore appears to shift the balance
strongly in favor of the host.
In addition to implications for the evolution of bacterial
virulence, this work sheds further light on mechanisms of Type
III secretion in Yersinia. It has been suggested that mRNA
sequence determines the secretion of TTSS effectors [40]. An
alternative proposal is that the amphipathic character of the N-
terminal amino acids controls the extent of secretion of TTSS
effectors [42]; this latter study further demonstrated that seemingly
minor changes in the amino acid sequence of a synthetic secretion
signal could result in dramatically different levels of secretion of a
reporter fusion construct. In agreement with this study, we
demonstrate that in the case of YopJ/P, the amino acid sequence
plays a key role in controlling secretion. It may be that alteration of
IS to SP at positions 10 and 11 generates a more optimal
amphipathic sequence leading to enhanced secretion and
translocation of YopP relative to YopJ. There may nonetheless
be a contribution from the mRNA sequence that is not revealed
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noncoding sequences with those of yopP to generate YopPJn from
YopJn led to markedly higher translocation of the corresponding
GSK fusion protein and secretion of the full length protein
(Figure 3B and Figure S1). We further observed that YopE was
also secreted at higher levels by Y. enterocolitica than Y.
pseudotuberculosis (Figure 4A). However, the yopE coding sequences
are identical between the two bacterial species. This suggests that
the rules governing the secretion of proteins that possess dedicated
chaperones (such as YopE) may differ from those that do not (such
as YopJ/P). Individual type III effector proteins may therefore
differ in the degree to which their secretion is governed by mRNA
or primary amino acid sequences.
It is notable that while bacteria secreting either YopJ or YopP
show cytotoxicity toward macrophages, as previously described
[16,17], only bacteria secreting YopP or hypersecreted mutants of
YopJ were cytotoxic toward DCs (Figures 1 and 3). This potent
cytotoxicity exhibited by Y. enterocolitica toward DCs may be a
confounding factor in the interpretation of some of the data
describing the inhibition of particular aspects of DC biology such
as maturation and phagocytosis [30,32]. We did not observe
reduced maturation of, or inhibition of cytokine secretion by DCs
infected by Y. pseudotuberculosis, in contrast to Y. enterocolitica infected
DCs (Figure S4). A recent study indicates, however, that YopJ of Y.
pestis can inhibit differentiation of monocytes into DCs and also
interferes with the ability of DCs to stimulate T cell proliferation
[53]. Many of these studies were performed with a monocytic cell
line which can be differentiated in vitro into DC-like cells or with
human monocytes isolated from peripheral blood samples.
Dendritic cells in vivo are not a uniform cell population, but rather
comprise a diverse array of closely related cells that differ in their
activation and antigen-presentation properties [54,55]. Further-
more, murine and human DC populations also differ with respect
to their activation properties and expression of TLR molecules
[56]. Experimental differences observed with different systems
may reflect potential differences between DC subsets in vivo.
Different subsets of DCs may therefore exhibit different matura-
tion or survival properties when targeted by Yersinia during in vivo
infection.
Macrophage resistance to cell death in response to inflamma-
tory stimuli such as LPS or bacterial infection is mediated by both
NF-kB and p38 MAPK-dependent transcription of a variety of
anti-apoptotic proteins [57,58]. Inhibition of both NF-kB and
MAPK signaling in the context of Yersinia infection is required for
the full extent of Yersinia-induced macrophage cell death [36].
Interestingly, pretreatment of DCs with the p38 MAPK inhibitor
SB202190 was sufficient to raise the level of DC death following Y.
pseudotuberculosis infection to that of Y. enterocolitica infected cells
(Figure 2D). We did not observe differences in the ability of Y.
pseudotuberculosis and Y. enterocolitica to inhibit IkB-a degradation in
either macrophages or DCs (data not shown). These findings
indicate that DCs and macrophages are differentially susceptible
to host cell death induced by Yersinia infection, and this may
depend on differential inhibition of MAPK pathways or
differential regulation of MAPK-dependent genes in macrophages
and dendritic cells during Yersinia infection. Data corroborating
these observations have also recently been reported by Adkins et
al. [59].
Conclusion
Our work uncovers a previously unappreciated feature of YopJ-
dependent cell death in the context of Yersinia infection.
Specifically, we have shown that this virulence property must be
carefully balanced during infection by Y. pseudotuberculosis, and that
shifting this balance in a way that leads to increased cell death
attenuates bacterial virulence. Similar findings have recently been
described in the organism Francisella novicida: bacterial genes were
identified that are necessary to tightly regulate the induction of
macrophage death in vitro, and mutants lacking these genes were
dramatically attenuated following mouse infection [60]. While this
is reasonable in light of the Francisella intracellular lifestyle, it is
surprising given the traditional viewpoint that the primary site of
Yersinia replication is extracellular. Our work therefore highlights
the importance of regulating host cell death during Yersinia
infection, and indicates that the appropriate regulation of
bacterially-induced host cell death may be a universal theme in
the pathogenesis of bacterial infection.
Materials and Methods
Cell culture
Bone marrow was isolated from 6–8 week old C57Bl/6 mice
and cultured in 12-well plates in DMEM containing 5% FCS in
the presence of GM-CSF for dendritic cells (DCs) [61] or 10%
FCS and 30% L929 cell supernatant for bone marrow
macrophages (BMMs) [62]. Cells were maintained at 37uCi na
5% CO2 humidified incubater. DCs were fed on days 2 and 4
post-isolation and infected on day 5 post-isolation. BMMs were
harvested and replated into 12 or 24-well plates on days 6–7 post-
isolation and infected the next day.
Bacterial strains and infection conditions
Strains used in this study are indicated in Table S1. Y.
pseudotuberculosis strain IP2666 and isogenic mutants were a kind
gift of Dr. James Bliska, SUNY Stonybrook. Y. enterocolitica strain
8081 was the gift of Dr. Denise Monack, Stanford University.
Bacteria were routinely grown at 26uC. For infection of cultured
cells, bacteria were grown shaking overnight at 26uCi n2 6YT
medium. Bacteria were diluted in 26YT containing 20 mM
MgCl2 and 20 mM sodium oxalate. Bacteria were grown shaking
for 1 hour at 26uC followed by 37uC for 2 hours to induce Yop
secretion [13]. Bacteria were harvested, washed three times with
DMEM and resuspended at the appropriate density in DMEM
before being added to cells. Bacteria were spun onto the cells at
1000 RPM for 5 minutes, and the infected cells placed in a
humidified tissue culture incubator at 37uC for 1 hour. Gentami-
cin was added to the cells 1 hour post-infection to a final
concentration of 100 mg/mL, and the cells placed in the incubator
until harvesting. LPS used in indicated experiments was O55:B5
obtained from Sigma (L2880).
Plasmid constructions
Primers used to amplify YopJ were identical to those previously
described [16]. A similar sized fragment containing both the ORF
and flanking regions of YopP was amplified from Y. enterocolitica
8081 DNA using the following primers: Forward 59-GAGA-
GAAAAGTTGCGAGAGCTG-39. Reverse 59-ACGTCGA-
TATGTCATGTATAT-39. Both YopJ and YopP amplified
fragments were cloned into the SphI/EagI sites of pACYC184.
pYopJP and pYopPJ were constructed by exchanging EcoNI/
BstEII fragments that contained the YopJ and YopP ORFs with
minimal flanking sequence from each of the parent plasmids. Site
directed mutant constructs were generated by PCR-based
mutagenesis using standard PCR conditions and primers contain-
ing altered base mutations. Multiple independently cloned
constructs were sequenced prior to further use. GSK-tag fusion
constructs were generated as follows: complimentary oligos
(Invitrogen) containing the first 39 nucleotides of the GSK-3b
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were annealed and ligated into the XcmI/BstEII sites of pYopJ,
pYopP, pYopJn, and pYopPJn plasmids.
Cell Death Assay
Cells were harvested 6 hours post-infection or 18–20 hours
post-infection as indicated, and washed twice with Annexin V
staining buffer (10 mM HEPES, 140 mM NaCl, 2.5 mM
CaCl2) before being stained with Annexin V (Molecular Probes)
and propidium iodide (Sigma) (1 mg/mL final concentration) as
described in the Vybrant apoptosis assay kit (Molecular Probes).
Detection of caspase-3 activation was done with the Nuc-
View
TM 488 Caspase-3 fluorescent substrate (Biotium, Inc.).
Flow cytometry was performed on a FACSCalibur (Becton
Dickinson) followed by analysis with FlowJo software (Treestar,
Inc.).
Western Blotting and Antibodies
Antibodies used were against cleaved PARP (R&D Systems)
and phospho- and total-MAPKs (Cell Signaling Technologies).
Antibodies against phospho-GSK-3b (Ser9) (#9336) and against
GSK-3b tag (#9325) were from Cell Signaling Technologies.
Secondary antibodies were horseradish peroxidase conjugated
anti-rabbit or anti-mouse (Jackson Immunoresearch). BMMs and
DCs were harvested 2 hrs post-infection for PARP cleavage and
at indicated times for phospho-MAPK detection. Cells were lysed
in buffer containing 50 mM Tris-HCl pH 8.0, 5 mM EDTA, 2%
Triton X-100, 0.02% sodium azide with protease inhibitors. 1/8
of each cell lysate was run on 12.5% SDS-PAGE and transferred
to PVDF membrane (Millipore Corporation) prior to Western
blotting. Detection was with ECL reagent (Amersham/GE
Healthcare).
Secreted Yop Analysis
Bacteria were grown overnight and diluted into 2xYT
containing 20 mM MgCl2 and 20 mM sodium oxalate as
described above. Bacteria were grown for 1 hr. at 25uC and
6 hr. at 37uC. The OD600 of the cultures were assayed and
bacteria were spun at 4000 RPM in a clinical centrifuge.
Supernatants were collected and precipitated with 10% TCA,
washed with acetone, air-dried and resuspended in SDS-PAGE
loading buffer. The protein samples were normalized for the
OD600, run on 10% SDS-PAGE gel and analyzed by staining with
Coomassie blue.
Analysis of YopJ/P translocation
The detection of translocated proteins was performed
essentially as described [44]. Briefly, HeLa cells were seeded
into 24 well dishes at a density of 3610
5 cells per well. Cells were
infected the following day with a yopJ mutant of Y. pseudotuber-
culosis expressing YopJGSK, YopPGSK,Y o p J n GSK, or YopPJnGSK
after first growing the bacteria in inducing conditions described
above. 2 hours prior to infection, cells were washed once with
DMEM without serum, and incubated in the same medium for
the rest of the experiment. Bacteria were harvested, washed 3
times in DMEM without serum, and added to the cells at an
MOI of 25. Bacteria were allowed to infect cells for three hours,
after which the cells were washed once with PBS, and lysed in
cell lysis buffer as described above. Cell lysates were run on 10%
SDS-PAGE gels, transferred to PVDF membrane, and probed
with polyclonal antibodies to phospho-GSK (Ser9). The blots
were then stripped and reprobed with polyclonal antibodies to
GSK tag (amino acids 1–13).
Mouse Infections
8–10 week old female C57Bl/6J mice were infected with 5610
8
to 1610
9 bacteria in 0.1 mL PBS by intragastric inoculation using
a feeding needle in accordance with Yale University approved
animal protocols. Mice were fasted for 14–16 hours prior to
infection. At indicated times post-infection, mice were sacrificed by
CO2 asphyxiation and the indicated organs harvested, homoge-
nized in PBS, and dilutions plated onto LB containing 2 mg/mL
irgasan. Blood was collected from infected mice just prior to
sacrificing by retro-orbital bleeding and centrifuged to collect
serum. Serum cytokines were assayed using the Luminex 200
instrument (Luminex Corp.) in combination with the BeadlyteH
Multicytokine Detection System 2 (Millipore).
TUNEL staining
Tissues from infected mice were isolated and cryopreserved in
OCT compound for sectioning or strained through nylon mesh to
generate single-cell suspensions for staining and flow-cytometry
analysis. For analysis of whole tissues, 10–12 mM thick sections
were cut, air-dried, and fixed in 4% paraformaldehyde, followed
by permeabilization in 0.1% citrate/0.1% Triton X-100. For
FACS analysis, tissues were stained with appropriate antibodies
(BD-Pharmingen) and fixed in 2% paraformaldehyde followed by
permeabilization as above. Following fixation and permeabiliza-
tion, tissues were stained with TUNEL reagent (Roche Applied
Science) according to manufacturer’s instructions and either
visualized by microscopy using a AxioPhot 2 Micropscope with
AxioVision software (Zeiss) or analyzed by flow cytometry as
described above. Single-stained and unstained samples were used
for compensation controls in accordance with standard FACS
procedures. TUNEL
+ populations were determined by gating on
cells present in TUNEL-stained samples that were absent in non-
TUNEL samples.
Supporting Information
Figure S1 N-terminal amino acid polymorphisms modulate
secretion levels of YopJ and YopP. (A) Schematic diagram of YopJ
and YopP constructs described in this work. YopJ and YopP open
reading frames were exchanged by digestion of pYopJ and pYopP
with EcoNI and BstEII and replacing the coding sequences of
YopJ/P from one vector with that of the other. (B) Alignment of
N-terminal region of yopJ and yopP genes with encoded amino acid
sequence. The non-coding sequences between the EcoNI site and
the translation start site are indicated in lower case. The EcoNI
site is underlined. (C) Sequence of YopJn, YopJ2nt and YopJ2aa
mutant constructs. (D) TCA precipitated supernatants from
indicated bacterial cultures grown in low calcium medium and
analyzed by SDS-PAGE.
Found at: doi:10.1371/journal.ppat.1000067.s001 (15.17 MB
PNG)
Figure S2 Low MOI infection of bone marrow derived
macrophages reveals difference in extent of cell death caused by
Y. enterocolitica and Y. pseudotuberculosis. Bone marrow derived
macrophages were infected with MOI of 5 with indicated bacterial
strains and assayed for annexin V and propidium iodide staining
18–20 hours post-infection.
Found at: doi:10.1371/journal.ppat.1000067.s002 (1.60 MB TIF)
Figure S3 Hypersescretion of YopJ attenuates Y. pseudotuberculosis
virulence. Mice were infected orally with 5610
8 cfu of indicated
bacterial strains and percent survival over time post-infection was
analyzed.
Found at: doi:10.1371/journal.ppat.1000067.s003 (1.32 MB TIF)
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pseudotuberculosis but not Y. enterocolitica or Y. pseudotuberculosis
expressing YopP. (A) CD40 and CD86 surface staining on DCs
18–20 hours post-infection with indicated bacterial strains. CD40
and CD86 are upregulated on DCs treated with LPS or wild-type
and plasmid-cured Y. pseudotuberculosis as well as plasmid-cured Y.
enterocolitica. No upregulation is observed on DCs infected with
wild-type Y. enterocolitica or Y. pseudotuberculosis expressing YopP. (B)
Secretion of IL-6 and IL-12 into DC culture supernatant was
assayed 18 hours post-infection. No cytokines are detectable in
culture supernatants from cells infected with Y. enterocolitica. The
presence of the Yersinia virulence plasmid does not appear to
inhibit cytokine production in DCs infected with wild-type Y.
pseudotuberculosis.
Found at: doi:10.1371/journal.ppat.1000067.s004 (1.87 MB TIF)
Table S1 Strains and plasmids used in this study.
Found at: doi:10.1371/journal.ppat.1000067.s005 (0.06 MB
DOC)
Table S2 Percent of cells containing b-lactamase activity after
infection with Y. pseudotuberculosis expressing YopE-BlaM fusion
protein.
Found at: doi:10.1371/journal.ppat.1000067.s006 (0.03 MB
DOC)
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